Thermal care of functional dyspepsia based on bicarbonate-sulphate-calcium water: A sequential clinical trial

Evidence-based Complementary and Alternative Medicine

Volumn 4, Issue 3, 2007, Pages 381-391

  Rocca, Giuseppe ^a,d   Dioni, Federico ^a   Rocca, Nadia ^a   Oliveri, Filippo ^b   Brunetto, Maurizia R ^b   Bonino, Ferruccio ^a,c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d Direzione Scientifica   (Italy)

Author keywords

Balneotherapy; Functional dyspepsia; Functional gastrointestinal disorders; Hydrotherapy; Sequential methods; Spa; Thermal care

Indexed keywords

BICARBONATE; CALCIUM; SULFATE;

ABDOMINAL DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DYSPEPSIA; FEMALE; HEARTBURN; HUMAN; MALE; PRIORITY JOURNAL; THERMAL ANALYSIS; TRADITIONAL MEDICINE; WATER TREATMENT;

EID: 52449086120     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nel100     Document Type: Article

References (48)

1. Longstreth GF. Functional dyspepsia - managing the conundrum. N Engl J Med 2006;354:791-3.
2. Saito YA, Locke GR 3rd, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol 2005;100:2743-8.
3. Chrubasik S, Chrubasik C, Torda T, Madisch A. Efficacy and tolerability of potato juice in dyspeptic patients: a pilot study. Phytomedicine 2006;13:11-5.
4. Panteris V, Karamanolis DG. Different aspects in functional dyspepsia. Hepatogastroenterology 2005;52:1782-91.
5. Oikawa T, Ito G, Koyama H, Hanawa T. Prokinetic effect of a Kampo medicine, Hange-koboku-to (Banxia-houpo-tang), on patients with functional dyspepsia. Phytomedicine 2005;12:730-4.
6. Drossman DA, RJ, Talley NJ, Thomson WG, Corazziari E, Whitehead WE. The Functional Gastrointestinal Disorders, Boston: Little Brown and Company, 1994.
7. Wicks D, Wright J, Rayment P, Spiller R. Impact of bitter taste on gastric motility. Eur J Gastroenterol Hepatol 2005;17:961-5.
8. Thijs JC, Kleibeuker JH. The management of uninvestigated dyspepsia in primary care. Minerva Gastroenterol Dietol 2005;51:213-24.
9. Schurman JV, Friesen CA, Danda CE, Andre L, Welchert E, Lavenbarg T, et al. Diagnosing functional abdominal pain with the Rome II criteria: parent, child, and clinician agreement. J Pediatr Gastroenterol Nutr 2005;41:291-5.
10. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999;45:II-37-42.
11. Vakil N, van Zanten SV, Chang L, Toth G, Sherman J, Fraser M, et al. Comprehension and awareness of symptoms in women with dyspepsia. Aliment Pharmacol Ther 2005;22:1147-55.
12. Hansen AN, Bergheim R, Fagertun H, Lund H, Wiklund I, Moum B. Long-term management of patients with symptoms of gastro-oesophageal reflux disease - a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting. Int J Clin Pract 2006;60:15-22.
13. Van den Heuvel-Janssen HA, Borghouts JA, Muris JW, Koes BW, Bouter LM, Knottnerus JA. Chronic non-specific abdominal complaints in general practice: a prospective study on management, patient health status and course of complaints. BMC Fam Pract 2006;7:12.
14. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 2005;129:1756-80.
15. Zhao L, Gan AP. Clinical and psychological assessment on xinwei decoction for treating functional dyspepsia accompanied with depression and anxiety. Am J Chin Med 2005;33:249-57.
16. Zhang WD, Wei BH, Chen ZS. [Schedule for diagnosis and treatment of functional indigestion syndrome with intergrative Chinese and Western medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi/Chinese Journal of Integrated Traditional and Western Medicine/Zhongguo Zhong Xi Yi Jie He Xue Hui, Zhongguo Zhong Yi Yan Jiu Yuan Zhu Ban. 2005;25:559-61.
17. Vasil'ev Iu V, Masharova AA, Ianova OB. [New alternative drug therapy for reducing symptoms associated with the functional gastric disorders]. Eksp Klin Gastroenterol 2005;4:39-41.
18. Talley NJ, Vakil N. Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005;100:2324-37.
19. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. New Engl J Med 2006;354:832-40.
20. Otaka M, Jin M, Odashima M, Matsuhashi T, Wada I, Horikawa Y, et al. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther 2005;21(Suppl 2):42-6.
21. See www.romecriteria.org for a comparison between Rome II and Rome III criteria.
22. In: Drossman D., Ed. The Functional Gastrointestinal Disorders. Rome II and the Multinational Working Teams, McLean: Degnon Associates, 2000.
23. Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 2005;54:1370-6.
24. Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. J Gastroenterol Hepatol 2005;20:1652-60.
25. Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA 2006;295:1566-76.
26. Talley NJ. American Gastroenterological Association. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 2005;129:1753-5.
27. Veldhuyzen van Zanten SJ, Bradette M, Chiba N, Armstrong D, Barkun A, Flook N, et al. Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol 2005;19:285-303.
28. Armitage P, Berry G. Statistical Methods in Medical Research, Oxford: Blackwell, 1994.
29. Wald A. Sequential Analysis, New York: Wiley, 1947.
30. Armitage P. Sequential Medical Trials, New York: Wiley, 1975, 42-8, 66, 157-8.
31. Whitehead J. The Design and Analysis of Sequential Clinical Trials, Horwood: Chichester, 1992.
32. Moayyedi P, Duffett S, Braunholtz D, Mason S, Richards ID, Dowell AC, Axon AT. The Leeds Dyspepsia Questionnaire:a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther 1998;12:1257-62.
33. Bertoni M, Olivieri F, manghetti M, Boccolini E, Bellomini MG, Blandizzi C, et al. Effects of a bicarbonate-alkaline mineral water on gastric functions and functional dyspepsia: a preclinical and clinical study. Pharmacol Res 2002;46:525-31.
34. Delgado-Aros S. [Gastric emptying and functional dyspepsia]. Gastroenterol Hepatol 2006;29:34-9.
35. Camilleri M, Bharucha AE. Drawing a blank in functional dyspepsia? Gastroenterology 2006;130:593-6.
36. Camilleri M. Dyspepsia is distinguishable from heartburn. Gut 2006;55:746-7.
37. Vandenberghe J, Vos R, Persoons P, Demyttenaere K, Janssens J, Tack J. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut 2005;54:914-9.
38. Vakil N. Dyspepsia and GERD: breaking the rules. Am J Gastroenterol 2005;100:1489-90.
39. Sarnelli G, Grasso R, Ierardi E, De Giorgi F, Savarese MF, Russo L, et al. Symptoms and pathophysiological correlations in patients with constipation and functional dyspepsia. Digestion 2005;71:225-30.
40. Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006;130:296-303.
41. Tack J, Lee KJ. Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol 2005;39:S211-6.
42. Tack J, Kindt S. Pathogenesis and therapy for idiopathic dyspepsia. Curr Gastroenterol Rep 2005;7:437-44.
43. Waldum HL, Martinsen TC, Brenna E. Nonulcer dyspepsia and proton pump inhibitors. Gastroenterology 2005;128:805.
44. Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol 2005;100:1477-88.
45. Vakil N. Toward a simplified strategy for managing dyspepsia. Postgrad Med 2005;117:13-6.
46. Smith ML. Functional dyspepsia pathogenesis and therapeutic options-implications for management. Dig Liver Dis 2005;37:547-58.
47. Sanft T, Jones MP. Functional dyspepsia: subgroups, history and outcomes. Minerva Gastroenterol Dietol 2005;51:225-34.
48. Ventura C. CAM and cell fate targeting: molecular and energetic insights into cell growth and differentiation. Evid Based Complement Alternat Med 2005;2:277-83.